Linkedin
Twitter
Space
Earth Observation
Science
Physics
Chemistry
Biology
Materials Science
Health
Antimicrobial Resistance (AMR)
Environment
Animal Health
Circular Economy
Climate Modelling
Food Production
Plastic Waste
PFAS
PFAS in the USA
Pollution
Energy
Critical Raw Materials
Canada
Energy Metals
Lithium Supply
Nickel
Graphite
Helium
Rare Earth Elements
Renewable Energy
Hydropower
Solar Energy
Wind Energy
Nuclear Energy
Fusion Energy
Careers in Nuclear Energy
Hydrogen Fuel
Energy Storage
Battery Production
Battery Recycling
Carbon Capture
Technology
Artificial Intelligence
Computer Science
Cyber Security
Digital Infrastructure
Disruptive Technology
High Performance Computing
Quantum’25
Transport
Electric Vehicles
EV Charging Infrastructure
EV Energy Storage
North America
Canada and Horizon Europe
Quantum’25
Partners
Project Partners
Partner News
The Innovation Platform
Special Focus Publications
eBooks
Special Reports
Videos
Subscribe
About Us
News
Latest Statistics
Search
Innovation News Network
EU Science, Research & Innovation News
Innovation News Network
EU Science, Research & Innovation News
Space
Earth Observation
Science
Physics
Chemistry
Biology
Materials Science
Health
Antimicrobial Resistance (AMR)
Environment
Animal Health
Circular Economy
Climate Modelling
Food Production
Plastic Waste
PFAS
PFAS in the USA
Pollution
Energy
Critical Raw Materials
Canada
Energy Metals
Lithium
Nickel
Graphite
Helium
Rare Earth Elements
Renewable Energy
Wind Energy
Solar Energy
Hydropower
Nuclear Energy
Fusion Energy
Careers in Nuclear Energy
Hydrogen
Energy Storage
Battery Production
Battery Recycling
Carbon Capture
Technology
Artificial Intelligence
Computer Science
Cyber Security
Digital Infrastructure
Disruptive Technology
High Performance Computing
Quantum’25
Transport
Electric Vehicles
EV Energy Storage
EV Charging Infrastructure
North America
Canada and Horizon Europe
Search
Linkedin
Twitter
Subscribe
News
Publications
Special Focus Publications
eBooks
Partners
Project Partners
Partner News
Special Reports
Videos
About Us
Testimonials
Our Management Team
Our Editors
Advanced Search
Latest Statistics
Diseases and Conditions
News
- Page 3
Transforming cancer care: MCTRC pioneers innovative research to bridge lab discoveries and patient treatment
Health
28th February 2025
McGill Centre for Translational Research in Cancer discuss the Centre’s essential role in advancing cancer research.
Strategising vaccine supply chains in developing countries
Health
14th February 2025
Learn more about the challenges and opportunities in optimising vaccine supply chains in developing countries such as Sierra Leone and Niger.
How diabetes fuels antibiotic resistance: What you need to know
Health
13th February 2025
Discover how diabetes accelerates antibiotic resistance, increasing the risk of untreatable infections. Find out more.
AI-powered breast cancer screening trial to revolutionise early detection in the UK
Health
4th February 2025
700,000 UK women will take part in the EDITH trial to test the effectiveness of AI in detecting breast cancer earlier. Find out more.
MHRA consults guidance on new personalised mRNA cancer vaccines
Health
3rd February 2025
Individualised mRNA cancer vaccines are a new type of cancer treatment that uses mRNA technology. Discover more here.
How vaccines can improve cardiovascular health in the EU
Health
19th December 2024
The EU needs additional measures to address existing gaps and enhance the effectiveness of initiatives to improve cardiovascular health.
Oxford University to lead new centres tackling untreatable diseases
Health
17th December 2024
The two new research centres aim to develop advanced treatments for currently untreatable diseases. Discover more here.
AI blood test revolutionises early breast cancer detection
Health
12th December 2024
Discover how an AI blood test detects early-stage breast cancer with 98% accuracy, paving the way for personalised cancer screening.
Oncopole: Québec’s catalyst for cancer research and innovation
Health
25th November 2024
Oncopole drives cancer research in Québec, uniting partners to accelerate innovation in treatment, prevention, and patient care.
Sugemalimab approved to treat adult patients with non-small cell lung cancer
Health
31st October 2024
The MHRA has approved the medicine sugemalimab (Eqjubi) to treat adult patients with non-small cell lung cancer. Read more here.
CMT Awareness Month: Raising awareness of a little-known condition
Health
24th October 2024
Many people are not aware of CMT disease, which can make everyday living and early medical diagnosis more difficult. Read more here.
The Université de Sherbrooke’s interdisciplinary approach for studying cancer in all its complexity
Health
24th October 2024
The Université de Sherbrooke's IRCUS is developing innovative interdisciplinary research to reduce the impact of cancer on affected people.
New saliva-based prostate cancer test could save NHS £500m
Health
14th October 2024
A revolutionary new prostate cancer test, which can be taken at home, could lead to thousands of earlier diagnoses for the NHS.
$7m ARPA-H funding will advance lung infection treatment
Health
11th October 2024
Researchers have been awarded up to $7m from ARPA-H to conduct research under the PROTECT project for lung infection treatment.
Artificial pancreas revolutionises type 1 diabetes care for thousands of NHS patients
Health
2nd October 2024
The NHS will provide tens of thousands of children and eligible adults with type 1 diabetes access to an 'artificial pancreas' device.
AI unlocks new path to personalised cancer treatments
Health
6th September 2024
Researchers are leveraging AI and molecular simulations to uncover new pathways for personalised cancer treatments.
Rice University awarded $18m to advance tumour removal technology
Health
20th August 2024
New funding will support the development of a new system to enhance the accuracy of tumour removal in breast, head and neck cancer.
Machine learning algorithm achieves 98% disease detection accuracy via tongue analysis
Health
13th August 2024
A new machine learning algorithm has demonstrated an impressive 98% accuracy in diagnosing various diseases.
NHS launches world first gene therapy for thalassaemia patients
Health
9th August 2024
NHS patients with beta thalassaemia will be among the first in the world to benefit from a pioneering gene therapy known as Casgevy.
Defence Therapeutics advances radio-immuno-conjugates with CNRI-H Program approval
Health
24th July 2024
Defence Therapeutics Inc. has announced a significant milestone in its radio-immuno-conjugates project. Find out more.
1
2
3
4
5
Page 3 of 5
Special Reports
Critical Raw Materials
Ensuring a circular economy in rare earth production
4th October 2022
Deep insights into sodium-ion batteries using calorimetric methods
27th September 2022
Platinum group element exploration begins at Mt Thirsty project
13th September 2022
The essential role of flake graphite in vehicle electrification
8th September 2022
Partner News
Partner News
Why component standardisation is the hidden key to industrial resilience
15th January 2026
Join the EUPEX workshop on ARM-based architectures at HiPEAC 2026
6th January 2026
Namibia Critical Metals secures over C$1.15m from warrant exercises
22nd December 2025
Claros Technologies validates breakthrough in PFAS destruction at commercial scale
19th December 2025
Special Reports Cont'd
Critical Raw Materials
5th September 2022
Green light for Eclipse’s Greenland rare earths exploration plans
Environment
1st September 2022
The vicious circle of drought and flood
Critical Raw Materials
24th August 2022
Lithium mining in Western Australia unearths the key to net zero
Energy
12th August 2022
Achieving net zero goals through optimising nuclear reactor safety
Partner News Cont'd
Partner News
19th December 2025
Maine PFAS testing lab rebrands to reflect growing national reach
Partner News
18th December 2025
BioNxt targets dysphagia with thin-film drug delivery breakthrough
Partner News
17th December 2025
First Hydrogen provides corporate overview for goals and developments
Partner News
16th December 2025
Perma-Fix and Enforcer One partner to accelerate transition to PFAS-free firefighting foams